Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular disease

Canadian Journal of Physiology and Pharmacology
Chris R TriggleMorley D Hollenberg

Abstract

Over the past 66 years, our knowledge of the role of the endothelium in the regulation of cardiovascular function and dysfunction has advanced from the assumption that it is a single layer of cells that serves as a barrier between the blood stream and vascular smooth muscle to an understanding of its role as an essential endocrine-like organ. In terms of historical contributions, we pay particular credit to (1) the Canadian scientist Dr. Rudolf Altschul who, based on pathological changes in the appearance of the endothelium, advanced the argument in 1954 that "one is only as old as one's endothelium" and (2) the American scientist Dr. Robert Furchgott, a 1998 Nobel Prize winner in Physiology or Medicine, who identified the importance of the endothelium in the regulation of blood flow. This review provides a brief history of how our knowledge of endothelial function has advanced and now recognize that the endothelium produces a plethora of signaling molecules possessing paracrine, autocrine, and, arguably, systemic hormone functions. In addition, the endothelium is a therapeutic target for the anti-diabetic drugs metformin, glucagon-like peptide I (GLP-1) receptor agonists, and inhibitors of the sodium-glucose cotransporter 2 (S...Continue Reading

References

Aug 1, 1977·Circulation Research·S M Schwartz, E P Benditt
Jun 1, 1991·The Journal of Pharmacy and Pharmacology·C WilcockC J Bailey
Oct 1, 1988·Hypertension·S MoncadaE A Higgs
Oct 23, 1986·The New England Journal of Medicine·P L LudmerP Ganz
Nov 1, 1995·Journal of the American College of Cardiology·T J AndersonA C Yeung
Sep 9, 1993·The American Journal of Cardiology·I T MeredithP Ganz
Mar 1, 1996·Journal of the American College of Cardiology·S B WilliamsM A Creager
Aug 18, 1997·Biochemical and Biophysical Research Communications·R M WeverT J Rabelink
Oct 8, 1997·Journal of the American College of Cardiology·H KawanoH Yasue
Nov 25, 1998·FEBS Letters·E StroesE E van Faassen
Jul 10, 1999·Journal of the American College of Cardiology·H KawanoH Yasue
Sep 14, 1999·Journal of the American College of Cardiology·T J Anderson
Dec 20, 2000·The Journal of Clinical Investigation·T MatobaA Takeshita
Apr 13, 2001·Journal of the American College of Cardiology·K J MatherT J Anderson
Oct 17, 2001·The Journal of Clinical Investigation·G ZhouD E Moller
Feb 6, 2002·Circulation·Subodh Verma, Todd J Anderson
Mar 20, 2002·Advances in Experimental Medicine and Biology·T J Anderson
Mar 20, 2002·The Journal of Clinical Investigation·Ming-Hui ZouRichard A Cohen
Aug 16, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Lisa M SemeniukDavid L Severson
Dec 17, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Ingrid Fleming, Rudi Busse
Feb 8, 2003·Circulation Research·Hiroto MiuraDavid D Gutterman
May 6, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Nikolaj IhlemannChristian Torp-Pedersen
Jun 14, 2003·Redox Report : Communications in Free Radical Research·Dominique Bonnefont-RousselotMonique Gardès-Albert
Oct 29, 2003·Circulation·Subodh VermaTodd J Anderson

❮ Previous
Next ❯

Citations

Dec 22, 2020·Frontiers in Physiology·Aleksei G Golubev
Dec 31, 2020·Biomedicines·Teresa SalvatoreFerdinando Carlo Sasso
Mar 13, 2021·Frontiers in Physiology·Jose A AdamsMarvin A Sackner
Apr 1, 2021·Trends in Microbiology·Samson Mathews SamuelDietrich Büsselberg
Apr 28, 2021·Physiology·Simone C da Silva RosaGary Sweeney

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

© 2021 Meta ULC. All rights reserved